Sinopharm Group Co. Ltd. (HKG:1099)

Market Cap	48.37B -16.5%
Revenue (ttm)	660.27B -0.7%
Net Income	8.19B +4.1%
EPS	2.62 +4.0%
Shares Out	3.12B
PE Ratio	5.91
Forward PE	5.37
Dividend	0.80 (5.25%)
Ex-Dividend Date	Jun 23, 2026

Volume	3,086,734
Open	15.47
Previous Close	15.50
Day's Range	15.26 - 15.50
52-Week Range	15.22 - 22.34
Beta	0.44
Analysts	Buy
Price Target	21.25 (+38.35%)
Earnings Date	Aug 21, 2026

About Sinopharm Group

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2003
• Employees: 90,447
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1099

Financial Performance

In 2025, Sinopharm Group's revenue was 575.17 billion, a decrease of -1.60% compared to the previous year's 584.51 billion. Earnings were 7.16 billion, an increase of 1.50%.

Financial numbers in CNY

Analyst Summary

According to 15 analysts, the average rating for 1099 stock is "Buy." The 12-month stock price target is $21.25, which is an increase of 38.35% from the latest price.

Price Target

$21.25

(38.35% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 11, 2026

Data Sources Report a data error